51. Disparity between scientific accomplishment and biotechnology availability in Brazil.
- Author
-
Braz LMA, Tahmasebi R, da Costa AC, and Witkin SS
- Subjects
- Biomedical Technology, Biotechnology, Brazil epidemiology, Humans, COVID-19 economics, COVID-19 epidemiology, Research economics, SARS-CoV-2
- Abstract
Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countries for the purchase of essential scientific-related products. Is this sustainable? Therefore it is necessary to draw the attention of all the world and Brazilian society about this situation.
- Published
- 2021
- Full Text
- View/download PDF